Abstract：Objective To evaluate the application value of continuous quality improvement in the management of highrisk drugs in obstetrics and gynecology.Methods The time before continuous quality improvement was set from February 2016 to February 2017,and the time from March 2017 to March 2018 was set as after improvement.The frequency of high-risk drug management defects before and after continuous quality improvement were recorded.Results The management of high-risk drugs in the gynecology and obstetrics ward was checked for 48 times,with 336 times recorded in total.The total frequency of defects before improvement was 110 times,higher than that after improvement for 16 times,which was statistically significant (P＜0.05)；after continuous quality improvement,the incidence rates of drugs mixed (0.06%),lack of identification (0.00%),the base number not supplemented in time (1.79%),management not standardized (1.79%),no professional management (0.00%),shift handover not carried out Unscientific (0.00%),poor management risk awareness (0.06%) were lower than before (4.76%,3.57%,5.95%,7.14%,2.38%,2.98%,5.95%),the differences were statistically significant (P＜0.05).The awareness of nurses after the improvement was 85.71%,higher than 47.61% after the improvement,and the difference was statistically significant (P＜0.05).Conclusion In the management of high-risk drugs in obstetrics and gynecology,the effect of continuous quality improvement is significant,which can improve the safety level of high-risk drug management,enhance the drug safety of patients,and improve the defects of high-risk drug management.
陈雪霞. 持续质量改进在妇产科高危药品管理中的应用[J]. 中国当代医药, 2020, 27(5): 190-192转196.
CHEN Xue-xia. Application of continuous quality improvement in the management of high risk drugs in obstetrics and gynecology. 中国当代医药, 2020, 27(5): 190-192转196.
Story L,Hutter J,Zhang T，et al.The use of antenatal fetal magnetic resonance imaging in the assessment of patients at high risk of preterm birth[J].Eur J Obstet Gynecol Reprod Biol，2018，222：134-141.
[9]
Carey ET,Moulder JK.Perioperative Management and implementation of enhanced recovery programs in gynecologic surgery for benign indications[J].Obstet Gynecol，2018，132（1）：137-146.
[10]
Cumyn A,Sauvé N,Rey E.Atrial fibrillation with a structurally normal heart in pregnancy：An international survey on current practice[J].Obstet Med，2017，10（2）：74-78.
[11]
Kalafat E,Sukur YE,Abdi A，et al.Metformin for prevention of hypertensive disorders of pregnancy in women with gestational diabetes or obesity：systematic review and metaanalysis of randomized trials[J].Ultrasound Obstet Gynecol，2018，52（6）：706-714.
[12]
El-Sayed AAF.Preeclampsia：A review of the pathogenesis and possible management strategies based on its pathophysiological derangements[J].Taiwan J Obstet Gynecol.，2017，56（5）：593-598.
京公网安备 11010502046607号